These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1733610)
1. Development of time-resolved immunofluorometric assay of vascular permeability factor. Yeo KT; Sioussat TM; Faix JD; Senger DR; Yeo TK Clin Chem; 1992 Jan; 38(1):71-5. PubMed ID: 1733610 [TBL] [Abstract][Full Text] [Related]
2. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Sioussat TM; Dvorak HF; Brock TA; Senger DR Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657 [TBL] [Abstract][Full Text] [Related]
4. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614 [TBL] [Abstract][Full Text] [Related]
5. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805 [TBL] [Abstract][Full Text] [Related]
8. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. Fava RA; Olsen NJ; Spencer-Green G; Yeo KT; Yeo TK; Berse B; Jackman RW; Senger DR; Dvorak HF; Brown LF J Exp Med; 1994 Jul; 180(1):341-6. PubMed ID: 8006592 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. Brown LF; Yeo KT; Berse B; Yeo TK; Senger DR; Dvorak HF; van de Water L J Exp Med; 1992 Nov; 176(5):1375-9. PubMed ID: 1402682 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Couffinhal T; Kearney M; Witzenbichler B; Chen D; Murohara T; Losordo DW; Symes J; Isner JM Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437 [TBL] [Abstract][Full Text] [Related]
13. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129 [TBL] [Abstract][Full Text] [Related]
14. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694 [TBL] [Abstract][Full Text] [Related]
15. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Dvorak HF; Senger DR Am J Pathol; 1993 Nov; 143(5):1255-62. PubMed ID: 8238242 [TBL] [Abstract][Full Text] [Related]
17. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. Qu-Hong ; Nagy JA; Senger DR; Dvorak HF; Dvorak AM J Histochem Cytochem; 1995 Apr; 43(4):381-9. PubMed ID: 7534783 [TBL] [Abstract][Full Text] [Related]